Back to Search Start Over

Somatostatin receptors in GtoPdb v.2023.1

Authors :
Hans-Jürgen Wester
Annamaria Vezzani
Giovanni Tulipano
John E. Taylor
Stefan Schulz
Agnes Schonbrunn
Herbert Schmid
Marcus Schindler
Jean-Claude Reubi
Terry Reisine
Yogesh C. Patel
Anne-Marie O'Carroll
Wolfgang Meyerhof
Shlomo Melmed
Amelie Lupp
Hans-Jürgen Kreienkamp
Patrick P. A. Humphrey
Daniel Hoyer
Leo Hofland
Rebecca Hills
Anthony Harmar
Wasyl Feniuk
Jacques Epelbaum
Pascal Dournaud
Micheal Culler
Zsolt Csaba
Justo P. Castaño
Corinne Bosquet
Source :
IUPHAR/BPS Guide to Pharmacology CITE. 2023
Publication Year :
2023
Publisher :
Edinburgh University Library, 2023.

Abstract

Somatostatin (somatotropin release inhibiting factor) is an abundant neuropeptide, which acts on five subtypes of somatostatin receptor (SST1-SST5; nomenclature as agreed by the NC-IUPHAR Subcommittee on Somatostatin Receptors [98]). Activation of these receptors produces a wide range of physiological effects throughout the body including the inhibition of secretion of many hormones. Endogenous ligands for these receptors are somatostatin-14 (SRIF-14) and somatostatin-28 (SRIF-28). cortistatin-14 has also been suggested to be an endogenous ligand for somatostatin receptors [61].

Subjects

Subjects :
General Medicine
General Chemistry

Details

ISSN :
26331020
Volume :
2023
Database :
OpenAIRE
Journal :
IUPHAR/BPS Guide to Pharmacology CITE
Accession number :
edsair.doi...........2791f45a551961c7fc7c6b315b9637b0